Lung cancer in pulmonary fibrosis: tales of epithelial cell plasticity
- PMID: 21502777
- DOI: 10.1159/000326299
Lung cancer in pulmonary fibrosis: tales of epithelial cell plasticity
Abstract
Lung epithelial cells exhibit a high degree of plasticity. Alterations to lung epithelial cell function are critically involved in several chronic lung diseases such as pulmonary fibrosis. Pulmonary fibrosis is characterized by repetitive injury and subsequent impaired repair of epithelial cells, which leads to aberrant growth factor activation and fibroblast accumulation. Increased proliferation and hyper- and metaplasia of epithelial cells upon injury have also been observed in pulmonary fibrosis; this epithelial cell activation might represent the basis for lung cancer development. Indeed, several studies have provided histopathological evidence of an increased incidence of lung cancer in pulmonary fibrosis. The mechanisms involved in the development of cancer in pulmonary fibrosis, however, remain poorly understood. This review highlights recently uncovered molecular mechanisms shared between lung cancer and fibrosis, which extend the current evidence of a common trait of cancer and fibrosis, as provided by histopathological observations.
Copyright © 2011 S. Karger AG, Basel.
Similar articles
-
Role of epithelial cells in idiopathic pulmonary fibrosis: from innocent targets to serial killers.Proc Am Thorac Soc. 2006 Jun;3(4):364-72. doi: 10.1513/pats.200601-003TK. Proc Am Thorac Soc. 2006. PMID: 16738202 Review.
-
WNT signaling in lung disease: a failure or a regeneration signal?Am J Respir Cell Mol Biol. 2010 Jan;42(1):21-31. doi: 10.1165/rcmb.2008-0485TR. Epub 2009 Mar 27. Am J Respir Cell Mol Biol. 2010. PMID: 19329555 Review.
-
CUX1/Wnt signaling regulates epithelial mesenchymal transition in EBV infected epithelial cells.Exp Cell Res. 2009 Jul 1;315(11):1819-31. doi: 10.1016/j.yexcr.2009.04.001. Epub 2009 Apr 8. Exp Cell Res. 2009. PMID: 19361498
-
Wnt/beta-catenin signaling: a novel target for therapeutic intervention of fibrotic kidney disease.Arch Pharm Res. 2009 Dec;32(12):1653-62. doi: 10.1007/s12272-009-2200-3. Epub 2010 Feb 17. Arch Pharm Res. 2009. PMID: 20162391 Review.
-
[Mechanisms in pulmonary fibrosis].Rev Prat. 2007 Dec 31;57(20):2222-6. Rev Prat. 2007. PMID: 18320741 Review. French.
Cited by
-
Indications for distinct pathogenic mechanisms of asbestos and silica through gene expression profiling of the response of lung epithelial cells.Hum Mol Genet. 2015 Mar 1;24(5):1374-89. doi: 10.1093/hmg/ddu551. Epub 2014 Oct 27. Hum Mol Genet. 2015. PMID: 25351596 Free PMC article.
-
Towards a global initiative for fibrosis treatment (GIFT).ERJ Open Res. 2017 Dec 1;3(4):00106-2017. doi: 10.1183/23120541.00106-2017. eCollection 2017 Oct. ERJ Open Res. 2017. PMID: 29214157 Free PMC article.
-
Epithelial-mesenchymal transition is driven by transcriptional and post transcriptional modulations in COPD: implications for disease progression and new therapeutics.Int J Chron Obstruct Pulmon Dis. 2019 Jul 18;14:1603-1610. doi: 10.2147/COPD.S208428. eCollection 2019. Int J Chron Obstruct Pulmon Dis. 2019. PMID: 31409985 Free PMC article.
-
Chemotherapy for extensive-stage small-cell lung cancer with idiopathic pulmonary fibrosis.Int J Clin Oncol. 2014 Apr;19(2):260-5. doi: 10.1007/s10147-013-0554-5. Epub 2013 Apr 17. Int J Clin Oncol. 2014. PMID: 23592279
-
Up-regulation of heparan sulfate 6-O-sulfation in idiopathic pulmonary fibrosis.Am J Respir Cell Mol Biol. 2014 Jan;50(1):106-14. doi: 10.1165/rcmb.2013-0204OC. Am J Respir Cell Mol Biol. 2014. PMID: 23962103 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
